Study Evaluating HKI-272 in Tumors

Clinical trial NCT00146172 · COMPLETED

Trial details

NCT number: NCT00146172
Sponsor: Puma Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2003-11-01
Primary completion: 2007-01-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.